Core Viewpoint - The inclusion of the HPV vaccine in China's national immunization program raises concerns about achieving sufficient vaccination rates to effectively protect against cervical cancer, with a target vaccination rate of 90% recommended by the World Health Organization [1][2]. Group 1: Vaccination Implementation Challenges - The National Health Commission announced that girls aged 13 and above will receive two doses of the bivalent HPV vaccine for free, but achieving high vaccination rates remains a challenge due to the need for parental involvement and the age group targeted [1][2]. - Current vaccination rates in some regions have improved from 60% to over 80%, but there is still a gap to reach the 90% target, necessitating further efforts to streamline the vaccination process [2]. - The coordination between health and education departments is crucial for implementing school-based vaccination programs, which face concerns about disrupting educational activities and increasing teachers' workloads [3][4]. Group 2: International Best Practices - Countries like the UK, Australia, and Singapore have successfully implemented school-based vaccination programs, achieving high coverage rates, while Rwanda and Bhutan have also seen success in reaching or nearing the 90% vaccination rate [3]. - A study in France indicated that school-based vaccination significantly increased coverage rates by 5.5%, particularly in areas with limited access to healthcare [3]. Group 3: Addressing Public Concerns - The importance of gaining support from educational institutions for vaccination initiatives is emphasized, as school notifications can enhance participation [4]. - Historical incidents of mass psychosomatic reactions during vaccination events highlight the need for careful planning and communication to maintain public trust in the HPV vaccine and the national immunization program [5]. - Effective public education and timely responses to controversies are essential to reassure parents and students about the safety and necessity of vaccinations, especially in the post-COVID-19 context where vaccine hesitancy has increased [5].